Terms: = Skin cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
25 results:
1. T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against hvem-over-expressing Melanoma Cell Lines.
Kim Y; Kim JE; Lee DY; Choi JU; Park JS; Lee HK; Choi SU; Park S; Park CH
Anticancer Res; 2023 Aug; 43(8):3419-3427. PubMed ID: 37500142
[TBL] [Abstract] [Full Text] [Related]
2. SOX10 Inhibits T Cell Recognition by Inducing Expression of the Immune Checkpoint Molecule PD-L1 in A375 Melanoma Cells.
Sasaki K; Hirohashi Y; Murata K; Minowa T; Nakatsugawa M; Murai A; Mizue Y; Kubo T; Kanaseki T; Tsukahara T; Iwabuchi S; Hashimoto S; Uhara H; Ishida-Yamamoto A; Torigoe T
Anticancer Res; 2023 Apr; 43(4):1477-1484. PubMed ID: 36974807
[TBL] [Abstract] [Full Text] [Related]
3. Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Saksena A; Jain A; Pack SD; Kim J; Lee I; Tyagi M; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):409-419. PubMed ID: 36461146
[TBL] [Abstract] [Full Text] [Related]
4. Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269787
[TBL] [Abstract] [Full Text] [Related]
5. Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.
Rossi E; Zizzari IG; Di Filippo A; Acampora A; Pagliara MM; Sammarco MG; Simmaco M; Lionetto L; Botticelli A; Bria E; Marchetti P; Blasi MA; Tortora G; Schinzari G; Nuti M
Hum Vaccin Immunother; 2022 May; 18(3):2034377. PubMed ID: 35258435
[TBL] [Abstract] [Full Text] [Related]
6. Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment: Defining a Viable Therapy.
Maniyar RR; Chakraborty S; Jarboe T; Suriano R; Wallack M; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():123-143. PubMed ID: 34888847
[TBL] [Abstract] [Full Text] [Related]
7. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects.
Rosenbaum SR; Tiago M; Caksa S; Capparelli C; Purwin TJ; Kumar G; Glasheen M; Pomante D; Kotas D; Chervoneva I; Aplin AE
Cell Rep; 2021 Dec; 37(10):110085. PubMed ID: 34879275
[TBL] [Abstract] [Full Text] [Related]
8. Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.
Bastidas Torres AN; Melchers RC; Van Grieken L; Out-Luiting JJ; Mei H; Agaser C; Kuipers TB; Quint KD; Willemze R; Vermeer MH; Tensen CP
Haematologica; 2022 Jul; 107(7):1619-1632. PubMed ID: 34382383
[TBL] [Abstract] [Full Text] [Related]
9. CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions.
Piotrowska M; Spodzieja M; Kuncewicz K; Rodziewicz-Motowidło S; Orlikowska M
Eur J Med Chem; 2021 Nov; 224():113694. PubMed ID: 34273660
[TBL] [Abstract] [Full Text] [Related]
10. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells.
Rindler K; Bauer WM; Jonak C; Wielscher M; Shaw LE; Rojahn TB; Thaler FM; Porkert S; Simonitsch-Klupp I; Weninger W; Mayerhoefer ME; Farlik M; Brunner PM
Front Immunol; 2021; 12():666935. PubMed ID: 33968070
[TBL] [Abstract] [Full Text] [Related]
11. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract] [Full Text] [Related]
12. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Ballotti R; Cheli Y; Bertolotto C
Mol Cancer; 2020 Dec; 19(1):170. PubMed ID: 33276788
[TBL] [Abstract] [Full Text] [Related]
13. Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma.
Razzaghi R; Agarwal S; Kotlov N; Plotnikova O; Nomie K; Huang DW; Wright GW; Smith GA; Li M; Takata K; Yamadi M; Yao C; O'Shea JJ; Phelan JD; Pittaluga S; Scott DW; Muppidi JR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33237303
[TBL] [Abstract] [Full Text] [Related]
14. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract] [Full Text] [Related]
15. Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and tnfrsf14 copy number loss.
Murphy LD; Orman GM; Bridge JA; Bajaj G; Gardner JM; Douglass DP
J Cutan Pathol; 2020 Oct; 47(10):970-975. PubMed ID: 32483824
[TBL] [Abstract] [Full Text] [Related]
16. Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity.
Érsek B; Silló P; Cakir U; Molnár V; Bencsik A; Mayer B; Mezey E; Kárpáti S; Pós Z; Németh K
Cell Mol Life Sci; 2021 Jan; 78(2):661-673. PubMed ID: 32328671
[TBL] [Abstract] [Full Text] [Related]
17. Differential modulation and prognostic values of immune-escape genes in uveal melanoma.
Basile MS; Mazzon E; Russo A; Mammana S; Longo A; Bonfiglio V; Fallico M; Caltabiano R; Fagone P; Nicoletti F; Avitabile T; Reibaldi M
PLoS One; 2019; 14(1):e0210276. PubMed ID: 30653520
[TBL] [Abstract] [Full Text] [Related]
18. Concomitant 1p36 deletion and tnfrsf14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract] [Full Text] [Related]
19. Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis.
Santos-Juanes J; Fernández-Vega I; Galache Osuna C; Coto-Segura P; Martínez-Camblor P
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):241-246. PubMed ID: 27592851
[TBL] [Abstract] [Full Text] [Related]
20. CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.
Thibult ML; Rivals JP; Mamessier E; Gertner-Dardenne J; Pastor S; Speiser DE; Derré L; Olive D
J Mol Med (Berl); 2013 Feb; 91(2):195-205. PubMed ID: 22903545
[TBL] [Abstract] [Full Text] [Related]
[Next]
